October 27, 2009
By: Lisa Henderson
Co-founder of investment firm set to acquire MDS Global Central Labs speaks out about his purchase.
 |
October 22, 2009
By:Marissa Shapiro
Why knowing a drug's risk and preparing for a risk evaluation mitigation strategy early on will considerably benefit a drug's development.
|
October 1, 2009
By:Lisa Henderson
Success and challenges for clinical trials that address these interrelated conditions.
|
October 1, 2009
By:Wayne R. Kubick
Is computer system interoperability for clinical data an impending reality or just a dream?
|
October 1, 2009
By:James Paskavitz
Delays and expenses can be spared by crafting plans earlier and more methodically
|
October 1, 2009
By:David Handelsman
How the ability to apply text mining and signal detection algorithms to social media's real-time data provides unheard of value.
|
October 1, 2009
By:Molly Blake-Michaels
A concise look at this nontraditional approach to clinical studies that explains the how and why of it.
|
October 1, 2009
By:Peter O'Donnell
The EU struggles to get over its regulatory hurdles in an effort to further R&D success.
|
| 
